Karma Biotechnologies
Karma is solving autoimmunity using Xavines to specifically switch off only the patient's rogue immune cells instead of their entire immune system.
- Stage Product In Development
- Industry Biotechnology
- Location Los Angeles, CA, USA
- Currency USD
- Founded March 2017
- Employees 3
- Incorporation Type C-corp
- Website karmabiotech.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.